Mild concussions linked to long-term brain changes: Cambridge study
HQ Team August 22, 2024: Even a mild concussion could lead to long-term changes in the brain, according to a new study conducted.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 22, 2024: Even a mild concussion could lead to long-term changes in the brain, according to a new study conducted.
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.
HQ Team July 18, 2024: Researchers at the Virginia Commonwealth University’s School of Medicine and the Richmond VA Medical Center say that almost.
By Aparna S May 14, 2024: A caregiver is a person who takes care of and provides for another individual who cannot take.
HQ Team February 29, 2024: A long-term study of more than a thousand 70 years old people found that those exposed to the.
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed.
HQ Team October 27, 2023: Millions of individuals managing diabetes rely on metformin to regulate their blood sugar levels. Recent research highlights the.
Researchers emphasize the potential benefits of short naps and the importance of maintaining overall brain health in preventing neurodegenerative conditions.
HQ Team May 17, 2023: People suffering from dementia can locate their phones, medicines, glasses, and other objects with the help of companion.
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.